142 reports of this reaction
1.6% of all DOPAMINE HYDROCHLORIDE reports
#10 most reported adverse reaction
PNEUMONIA is the #10 most commonly reported adverse reaction for DOPAMINE HYDROCHLORIDE, manufactured by Deseret Biologicals, Inc.. There are 142 FDA adverse event reports linking DOPAMINE HYDROCHLORIDE to PNEUMONIA. This represents approximately 1.6% of all 8,648 adverse event reports for this drug.
Patients taking DOPAMINE HYDROCHLORIDE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for DOPAMINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for DOPAMINE HYDROCHLORIDE:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 142 FDA reports for DOPAMINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 1.6% of all adverse event reports for DOPAMINE HYDROCHLORIDE, making it a notable side effect.
If you experience pneumonia while taking DOPAMINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.